At a glance
ClinicalIndex Comparison RecordN/ACompleted· 353 enrolled
Drug / intervention
Blood sample(10cc) collectionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open, Parallel, Single-Site Study to Evaluate Sensitivity and Specificity of Newly Defined Diagnosed-biomarker for Gastric Cancer Pts and Cancer-free Healthy Volunteers
In Brief
An observational study evaluating Blood sample(10cc) collection for Gastric Cancer. Completed, enrolled 353 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate sensitivity and specificity of newly defined tumor biomarker with gastric cancer pts and cancer-free healthy volunteers.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastric Cancer
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
First PostedJul 2016
Primary CompletionAug 2016
Study CompletionSep 2017
TodayJul 2026
First PostedJul 28, 2016
Enrollment StartJul 1, 2015
Primary CompletionAug 1, 2016
Study CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.9 years ago
Interventions
Blood sample(10cc) collectionprocedure
In both groups, serum haptoglobins to be collected and analyzed